A detailed history of Level Four Advisory Services, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Level Four Advisory Services, LLC holds 79,636 shares of MRK stock, worth $7.76 Million. This represents 0.39% of its overall portfolio holdings.

Number of Shares
79,636
Previous 93,176 14.53%
Holding current value
$7.76 Million
Previous $11.5 Million 21.6%
% of portfolio
0.39%
Previous 0.55%

Shares

33 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$111.15 - $128.97 $1.5 Million - $1.75 Million
-13,540 Reduced 14.53%
79,636 $9.04 Million
Q2 2024

Aug 09, 2024

BUY
$123.8 - $132.96 $1.82 Million - $1.95 Million
14,690 Added 18.72%
93,176 $11.5 Million
Q1 2024

May 13, 2024

BUY
$113.24 - $131.95 $10,191 - $11,875
90 Added 0.11%
78,486 $10.4 Million
Q4 2023

Feb 08, 2024

SELL
$100.18 - $109.02 $410,838 - $447,091
-4,101 Reduced 4.97%
78,396 $8.55 Million
Q3 2023

Nov 13, 2023

SELL
$102.95 - $114.33 $698,412 - $775,614
-6,784 Reduced 7.6%
82,497 $8.49 Million
Q2 2023

Jul 10, 2023

SELL
$108.61 - $118.38 $582,584 - $634,990
-5,364 Reduced 5.67%
89,281 $10.3 Million
Q1 2023

Jun 05, 2023

BUY
$102.94 - $114.86 $414,333 - $462,311
4,025 Added 4.44%
94,645 $10.1 Million
Q4 2022

Feb 13, 2023

BUY
$87.44 - $112.11 $2.66 Million - $3.41 Million
30,399 Added 50.48%
90,620 $10.1 Million
Q3 2022

Nov 07, 2022

SELL
$84.53 - $94.96 $392,810 - $441,279
-4,647 Reduced 7.16%
60,221 $5.19 Million
Q2 2022

Aug 08, 2022

BUY
$83.49 - $94.64 $31,976 - $36,247
383 Added 0.59%
64,868 $5.91 Million
Q1 2022

May 10, 2022

BUY
$73.51 - $82.4 $625,423 - $701,059
8,508 Added 15.2%
64,485 $5.29 Million
Q4 2021

Feb 11, 2022

BUY
$72.28 - $90.54 $1.07 Million - $1.34 Million
14,771 Added 35.85%
55,977 $4.29 Million
Q3 2021

Oct 12, 2021

SELL
$71.68 - $78.83 $270,376 - $297,346
-3,772 Reduced 8.39%
41,206 $3.1 Million
Q2 2021

Aug 09, 2021

BUY
$70.31 - $77.77 $463,131 - $512,270
6,587 Added 17.16%
44,978 $3.5 Million
Q1 2021

May 10, 2021

SELL
$68.86 - $81.11 $721,652 - $850,032
-10,480 Reduced 21.44%
38,391 $2.96 Million
Q4 2020

Feb 10, 2021

SELL
$71.77 - $79.65 $38,612 - $42,851
-538 Reduced 1.09%
48,871 $4 Million
Q3 2020

Nov 02, 2020

SELL
$73.18 - $82.95 $2.44 Million - $2.77 Million
-33,365 Reduced 40.31%
49,409 $4.1 Million
Q2 2020

Aug 17, 2020

BUY
$70.42 - $80.13 $5.83 Million - $6.63 Million
82,774 New
82,774 $6.41 Million
Q2 2020

Jul 27, 2020

SELL
$70.42 - $80.13 $2.76 Million - $3.14 Million
-39,128 Closed
0 $0
Q1 2020

May 13, 2020

BUY
$63.36 - $87.82 $58,037 - $80,443
916 Added 2.4%
39,128 $3.01 Million
Q4 2019

Feb 13, 2020

BUY
$77.58 - $87.54 $160,280 - $180,857
2,066 Added 5.72%
38,212 $11.3 Million
Q3 2019

Nov 12, 2019

SELL
$76.08 - $82.93 $204,503 - $222,915
-2,688 Reduced 6.92%
36,146 $3.04 Million
Q2 2019

Aug 14, 2019

BUY
$69.84 - $81.59 $200,720 - $234,489
2,874 Added 7.99%
38,834 $3.26 Million
Q1 2019

May 15, 2019

BUY
$69.58 - $79.36 $31,519 - $35,950
453 Added 1.28%
35,960 $2.99 Million
Q4 2018

Feb 08, 2019

BUY
$65.24 - $75.71 $255,936 - $297,010
3,923 Added 12.42%
35,507 $2.71 Million
Q3 2018

Nov 14, 2018

SELL
$57.69 - $67.84 $252,162 - $296,528
-4,371 Reduced 12.16%
31,584 $2.24 Million
Q2 2018

Aug 14, 2018

SELL
$50.83 - $59.72 $106,336 - $124,934
-2,092 Reduced 5.5%
35,955 $2.18 Million
Q1 2018

May 14, 2018

BUY
$50.96 - $59.23 $220,809 - $256,643
4,333 Added 12.85%
38,047 $2.07 Million
Q4 2017

Feb 13, 2018

BUY
$51.62 - $61.64 $194,349 - $232,074
3,765 Added 12.57%
33,714 $1.9 Million
Q3 2017

Apr 03, 2018

SELL
$58.67 - $63.13 $51,570 - $55,491
-879 Reduced 2.85%
29,949 $1.92 Million
Q3 2017

Nov 15, 2017

BUY
$58.67 - $63.13 $192,261 - $206,877
3,277 Added 11.89%
30,828 $1.98 Million
Q2 2017

Sep 20, 2017

SELL
N/A
-10,344 Reduced 27.3%
27,551 $1.75 Million
Q1 2017

Sep 20, 2017

BUY
N/A
37,895
37,895 $2.41 Million

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $247B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Level Four Advisory Services, LLC Portfolio

Follow Level Four Advisory Services, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Level Four Advisory Services, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Level Four Advisory Services, LLC with notifications on news.